Innovus Pharmaceuticals Inc. (fka INNV)

[John Kent]

Innovus Pharma Enters the $11 Billion Glucose Monitoring Market with FDA-Cleared Products via an Expanded Agreement with ACON Laboratories, Inc.

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced that it has entered into an additional agreement with current partner ACON Laboratories, Inc. (“ACON Labs”). ACON Labs is a San Diego-based diagnostic product manufacturer who will supply Innovus Pharma with its U.S. Food and Drug Administration’s (“FDA”) cleared glucose monitor, test strips and lancet device (the “GlucoGorx® Kit”). Innovus Pharma will offer the GlucoGorx™ Kit, which will provide highly sensitive glucose level testing results within 4 seconds, to its customers who buy its GlucoGorx™ clinical glucose supplement.

According to WebMD, diabetes is a lifelong disease. As of 2017, approximately 18.2 million Americans have been diagnosed with the disease and almost one-third (approximately 5.2 million) are unaware that they are living with it. An additional 41 million people have pre-diabetes and those with diabetes need to manage the disease to stay healthy; as of today, there is no cure for diabetes.

With an FDA-cleared glucometer and test strips, Innovus Pharma is now eligible to enter reimbursement and government supply programs, expanding the addressable market significantly for this product.

“We are proud to expand our partnership and to be working with ACON to add the GlucoGorx™ glucose monitor, strips and lancet device for our customers. The creation of a kit for monitoring a diabetic’s blood suger levels expands our GlucoGorx™ clinical supplement offerings,” stated Dr. Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. “We strongly believe our GlucoGorx™ customers will be able to use our FDA cleared kit to monitor their blood sugar levels from the convenience of their own homes. We are excited that Innovus Pharma is entering this large glucose monitoring market and we look forward to offering GlucoGorx™ and the GlucoGorx™ Kit in the first half of 2018," he continued.

http://www.otcmarkets.com/stock/INNV/news/Innovus-Pharma-Enters-the--11-Billion-Glucose-Monitoring-Market-with-FDA-Cleared-Products-via-an-Expanded-Agreement-with-ACON-Laboratories--Inc-?id=174979&b=y